| Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting ONECUT2 M Shen, C Dong, X Ruan, W Yan, M Cao, D Pizzo, X Wu, L Yang, L Liu, ... Cancer research 79 (14), 3608-3621, 2019 | 164 | 2019 |
| Antitumor effects of anlotinib in thyroid cancer X Ruan, X Shi, Q Dong, Y Yu, X Hou, X Song, X Wei, L Chen, M Gao Endocrine-related cancer 26 (1), 153-164, 2019 | 86 | 2019 |
| LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma X Hou, X Shi, W Zhang, D Li, L Hu, J Yang, J Zhao, S Wei, X Wei, X Ruan, ... Cell death & disease 12 (4), 347, 2021 | 58 | 2021 |
| KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway W Zhang, X Ruan, Y Li, J Zhi, L Hu, X Hou, X Shi, X Wang, J Wang, W Ma, ... Theranostics 12 (4), 1500, 2022 | 53 | 2022 |
| Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth M Cao, R Isaac, W Yan, X Ruan, L Jiang, Y Wan, J Wang, E Wang, ... Nature cell biology 24 (6), 954-967, 2022 | 52 | 2022 |
| Rho differentially regulates the Hippo pathway by modulating the interaction between Amot and Nf2 in the blastocyst X Shi, Z Yin, B Ling, L Wang, C Liu, X Ruan, W Zhang, L Chen Development 144 (21), 3957-3967, 2017 | 51 | 2017 |
| Chemotherapy induces breast cancer stemness in association with dysregulated monocytosis L Liu, L Yang, W Yan, J Zhai, DP Pizzo, P Chu, AR Chin, M Shen, C Dong, ... Clinical Cancer Research 24 (10), 2370-2382, 2018 | 48 | 2018 |
| Targeting super-enhancer-driven oncogenic transcription by CDK7 inhibition in anaplastic thyroid carcinoma X Cao, L Dang, X Zheng, Y Lu, Y Lu, R Ji, T Zhang, X Ruan, J Zhi, X Hou, ... Thyroid 29 (6), 809-823, 2019 | 45 | 2019 |
| Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote skeletal muscle proteolysis W Yan, M Cao, X Ruan, L Jiang, S Lee, A Lemanek, M Ghassemian, ... Nature cell biology 24 (5), 793-804, 2022 | 43 | 2022 |
| Apatinib inhibits cell proliferation and induces autophagy in human papillary thyroid carcinoma via the PI3K/Akt/mTOR signaling pathway X Meng, H Wang, J Zhao, L Hu, J Zhi, S Wei, X Ruan, X Hou, D Li, ... Frontiers in Oncology 10, 217, 2020 | 42 | 2020 |
| C14orf93 (RTFC) is identified as a novel susceptibility gene for familial nonmedullary thyroid cancer C Liu, Y Yu, G Yin, J Zhang, W Wen, X Ruan, D Li, S Zhang, W Cai, M Gao, ... Biochemical and biophysical research communications 482 (4), 590-596, 2017 | 25 | 2017 |
| TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57KIP2 repression X Li, X Ruan, P Zhang, Y Yu, M Gao, S Yuan, Z Zhao, J Yang, L Zhao Oncogene 37 (21), 2773-2792, 2018 | 24 | 2018 |
| Genome-wide identification of m6A-associated functional SNPs as potential functional variants for thyroid cancer X Ruan, M Tian, N Kang, W Ma, Y Zeng, G Zhuang, W Zhang, G Xu, L Hu, ... American Journal of Cancer Research 11 (11), 5402, 2021 | 19 | 2021 |
| Inhibition of BRAF sensitizes thyroid carcinoma to immunotherapy by enhancing tsMHCII-mediated immune recognition J Zhi, P Zhang, W Zhang, X Ruan, M Tian, S Guo, W Zhang, X Zheng, ... The Journal of Clinical Endocrinology & Metabolism 106 (1), 91-107, 2021 | 19 | 2021 |
| Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer W Xie, Y Sun, Y Zeng, L Hu, J Zhi, H Ling, X Zheng, X Ruan, M Gao Bioengineered 13 (1), 190-205, 2022 | 17 | 2022 |
| Integrated microRNA‑mRNA analyses of distinct expression profiles in follicular thyroid tumors J Chi, X Zheng, M Gao, J Zhao, D Li, J Li, L Dong, X Ruan Oncology Letters 14 (6), 7153-7160, 2017 | 17 | 2017 |
| High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion J Zhao, X Yun, X Ruan, J Chi, Y Yu, Y Li, X Zheng, M Gao OncoTargets and therapy, 1309-1318, 2019 | 14 | 2019 |
| Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib L Hu, J Zhang, M Tian, N Kang, G Xu, J Zhi, X Ruan, X Hou, W Zhang, J Yi, ... Cell death & disease 13 (2), 124, 2022 | 13 | 2022 |
| Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma J Zhi, Y Wu, L Hu, J Zhao, H Liu, X Ruan, X Hou, J Zhang, X Zheng, ... International Journal of Clinical Oncology 25, 59-66, 2020 | 12 | 2020 |
| METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer J Ning, X Hou, J Hao, W Zhang, Y Shi, Y Huang, X Ruan, X Zheng, M Gao Cell Death & Differentiation 30 (10), 2265-2279, 2023 | 9 | 2023 |
